Previous reports have documented the co-occurrence of extra-adrenal tumors, such as breast cancer, parathyroid tumors, thyroid cancer, and thyroid adenomas, in individuals with ARMC5 variants [4]. Here, ARMC5 is linked to breast carcinoma.